Professor Anatolii Melnyk, Head of the Department of Electronic Computing Machines, Yurii Morozov, Associate Professor, Bohdan Havanio, postgraduate student, Petro Hupalo, a third-year student, and Ostap Otserklevych, this year’s master’s graduate, decided to develop mobile applications for round-the-clock monitoring of pulmonary function in Covid-19 patients.
– When we learned about a large-scale competition covering all methods of combating coronavirus, announced by the Francophone University Agency, we had the idea – to develop applications that will continuously monitor the main organ – the lungs, which are most affected by coronavirus, and that is why they need constant medical monitoring. Our applications are based on wireless devices and are designed so that you can monitor lung conditions around the clock and regardless of the patient’s location, says Anatolii Melnyk, Head of the ECM Department.
About two thousand projects were submitted to the competition. At first, the organizers did not expect that there would be such activity, so during the competition itself, they decided to double the planned amount of prize money. Lviv Polytechnicians entered the list of 92 participants who won the competition.
The next step of our group of developers is practical implementation of the project and its trial operation. Liubomyr Rak, Director of the Pulmonary Health Centre in Lviv, readily agreed. Thus, the devices of the research group of the ECM Department will allow a doctor to continuously see blood oxygen level, heart rate and temperature of the patient at a distance (e.g. from his office). This information will be sent to the server, where the doctor will receive a message about the patient’s condition and decide on further treatment.
With this application, physicians will be able to monitor their patients, who are in hospital wards and at home, on observation or outpatient care. In this way, it will be possible to monitor the condition of the sick not only with Covid-19, but also with other diseases, for example, asthma or cancer.